Key result
The novel de novo F747S variant in CACNA1D caused a strong gain-of-function with a -28 mV shift in activation voltage, explaining the patient's severe jittering phenotype.
Why the study?
Germline gain-of-function missense variants in the Cav1.3 alpha1-subunit (CACNA1D gene) confer high risk for severe neurodevelopmental disorders, but the phenotypic spectrum and functional consequences of novel variants require characterization.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
The novel F747S variant in CACNA1D causes a severe gain-of-function channelopathy with a novel jittering phenotype, which shows increased in vitro sensitivity to isradipine, suggesting a potential off-label treatment.
Germline gain-of-function missense variants in the pore-forming Cav1.3 α1-subunit (CACNA1D gene) confer high risk for a severe neurodevelopmental disorder with or without endocrine symptoms. Here, we report a 4-week-old new-born with the novel de novo missense variant F747S with a so far not described prominent jittering phenotype in addition to symptoms previously reported for CACNA1D mutations including developmental delay, elevated aldosterone level and transient hypoglycemia. We confirmed the pathogenicity of this variant in whole-cell patch-clamp experiments with wild-type and F747S mutant channels heterologously expressed together with α2δ1 and cytosolic β3 or membrane-bound β2a subunits. Mutation F747S caused the quantitatively largest shift in the voltage dependence of activation (-28 mV) reported so far for CACNA1D germline mutations. It also shifted inactivation to more negative voltages, slowed the time course of current inactivation and slowed current deactivation upon repolarization with both co-expressed β-subunits. In silico modelling and molecular docking, simulations revealed that this gain-of-function phenotype can be explained by formation of a novel inter-domain hydrogen bond between mutant residues S747 (IIS6) with N1145 (IIIS6) stabilizing selectively the activated open channel state. F747S displayed 2-6-fold increased sensitivity for the L-type Ca2+ channel blocker isradipine compared to wild type. Our data confirm the pathogenicity of the F747S variant with very strong gain-of-function gating changes, which may contribute to the novel jittering phenotype. Increased sensitivity for isradipine suggests this drug for potential symptomatic off-label treatment for carriers of this mutation.
No takes yet. Share an insight, caveat, or question.
Török et al. (2022) conducted a case report in CACNA1D Ca2+ channelopathy (n=1). F747S missense variant in CACNA1D vs. Wild-type channels was evaluated on Voltage dependence of activation and channel gating properties (-28 mV shift in voltage dependence of activation). The novel de novo F747S variant in CACNA1D caused a strong gain-of-function with a -28 mV shift in activation voltage, explaining the patient's severe jittering phenotype.
Synapse has enriched 10 related papers. Consider them for comparative context: